electroCore (ECOR) Depreciation and Depletion (2018 - 2019)
electroCore's (ECOR) quarterly Depreciation and Depletion came in at $27480.0 in Q4 2019, up 10.2% year-on-year from $24936.0 in Q4 2018, and little changed quarter-over-quarter from $27366.0 in Q3 2019.
electroCore (ECOR) Depreciation and Depletion (2018 - 2019) Analysis & Trends
electroCore's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $27480.0 for Q4 2019.
- On a quarterly basis, Depreciation and Depletion rose 10.2% year-over-year to $27480.0 in Q4 2019; TTM through Dec 2019 was $100445.0, a N/A change from a year earlier, with the FY2019 full-year figure at $108546.0, up 62.83% from the prior year.
- Depreciation and Depletion steadied at $27480.0 in Q4 2019 per ECOR's latest filing, from $27366.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $27480.0 in Q4 2019 and bottomed at $20663.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 27,480.00 |
| Dec 31, 2019 | 27,480.00 |
| Sep 30, 2019 | 27,366.00 |
| Sep 30, 2019 | 27,366.00 |
| Dec 31, 2018 | 24,936.00 |
| Dec 31, 2018 | 24,936.00 |
| Sep 30, 2018 | 20,663.00 |
| Sep 30, 2018 | 20,663.00 |